Iterum Therapeutics plc is a pharmaceutical company focused on maximizing the commercial potential of ORLYNVAH (sulopenem etzadroxil-probenecid), the first oral branded penem antibiotic approved in the United States. ORLYNVAH is FDA-approved for treating uncomplicated urinary tract infections (uUTIs) in adult women. The company also develops IV sulopenem for complicated UTIs and intra-abdominal infections, and is pursuing strategic alternatives including sale, licensing, or commercialization of its sulopenem program.
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-02-07 | 2024-12-31 | 0000950170-25-015857 | EDGAR | 143K words |
| 2024-03-28 | 2023-12-31 | 0000950170-24-037615 | EDGAR | 137K words |
| 2023-03-16 | 2022-12-31 | 0000950170-23-008300 | EDGAR | 125K words |
| 2022-03-28 | 2021-12-31 | 0001564590-22-011897 | EDGAR | — |
| 2021-03-12 | 2020-12-31 | 0001564590-21-012694 | EDGAR | — |
| 2020-03-12 | 2019-12-31 | 0001564590-20-010242 | EDGAR | — |
| 2019-03-25 | 2018-12-31 | 0001564590-19-009089 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001193125-25-281557 | EDGAR | 89K words |
| 2025-08-05 | 2025-06-30 | 0000950170-25-102400 | EDGAR | 84K words |
| 2025-05-13 | 2025-03-31 | 0000950170-25-069802 | EDGAR | 81K words |
| 2024-11-14 | 2024-09-30 | 0000950170-24-126736 | EDGAR | 85K words |
| 2024-08-14 | 2024-06-30 | 0000950170-24-096653 | EDGAR | 91K words |
| 2024-05-13 | 2024-03-31 | 0000950170-24-058200 | EDGAR | 85K words |
| 2023-11-14 | 2023-09-30 | 0000950170-23-063353 | EDGAR | 88K words |
| 2023-08-11 | 2023-06-30 | 0000950170-23-041604 | EDGAR | 85K words |
| 2023-05-12 | 2023-03-31 | 0000950170-23-021500 | EDGAR | 83K words |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024161 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0000950170-22-017000 | EDGAR | — |
| 2022-05-13 | 2022-03-31 | 0000950170-22-009792 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-31 | 0001193125-26-133247 | EDGAR | 1K words |
| 2026-03-27 | 0001193125-26-127785 | EDGAR | 1K words |
| 2026-03-03 | 0001193125-26-088494 | EDGAR | 1K words |
| 2026-03-02 | 0001193125-26-085646 | EDGAR | 1K words |
| 2026-02-18 | 0001193125-26-057393 | EDGAR | 1K words |
| 2025-12-12 | 0001193125-25-317728 | EDGAR | 1K words |
| 2025-11-14 | 0001193125-25-281531 | EDGAR | 3K words |
| 2025-10-16 | 0001193125-25-241556 | EDGAR | 1K words |
| 2025-09-10 | 0000950170-25-113986 | EDGAR | 1K words |
| 2025-08-28 | 0000950170-25-111974 | EDGAR | 1K words |
193 total filings indexed. 164 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001659323 |
| Ticker | ITRM |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | L2 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ITRM (~200 tokens, structured JSON with cryptographic provenance)